• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Glenmark gets US FDA nod for the generic version of Taytulla Capsules

    EXPRESS PHARMA

    Glenmark gets USFDA nod for contraceptive tablets

    ECONOMICTIMES

    Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg

    FDA

    Glenmark receives ANDA approval for Norethindrone Acetate & Ethinyl Estradiol

    EQUITYBULLS

    Mylan Lab’s Generic Ethinyl Estradiol; Norethindrone Acetate Receives Approval In US

    FDA

    Enforcement Report - Week of August 23, 2017

    FDA

    Aurobindo Pharma’s Generic Cigensa Norethindrone Acetate;Ethinyl Estradiol; Ethinyl Estradiol;Ferrous Fumarate Receives Tentative Approval In US

    FDA

    Enforcement Report - Week of May 31, 2017

    FDA

    Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas™ 24 Fe Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information

    FDA

    Allergan Announces Launch of Taytulla, the First Contraceptive Softgel Capsule

    PR NEWSWIRE

    Lupin`s Generic Norethindrone,Ethinyl Estradiol,Ferrous Fumarate approved in US to prevent pregnancy

    FDA

    India`s Polydrug Labs fails EDQM inspection

    Mylan Launches First Generic Version of Generess Fe®

    MYLAN

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.